Mustang Bio MBIO
NASDAQ MBIO
$0.44 -0.01 (-2.24%)
As of: Nov 11, 2026 · 2:59 PM EST

Mustang Bio (MBIO) Current Deferred Revenue (2021 - 2026)

Updated

Analysis

Mustang Bio (MBIO) Current Deferred Revenue (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Mustang Bio 3.03 Mn -60.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 150,000.00
Jun 30, 2026 150,000.00
Mar 31, 2026 150,000.00
Dec 31, 2025 150,000.00
Sep 30, 2025 150,000.00
Jun 30, 2025 150,000.00
Mar 31, 2025 150,000.00
Dec 31, 2024 150,000.00
Sep 30, 2024 -1.30 Mn
Jun 30, 2024 -1.40 Mn
Mar 31, 2024 270,000.00
Dec 31, 2023 270,000.00
Sep 30, 2023 270,000.00
Jun 30, 2023 270,000.00
Mar 31, 2023 270,000.00
Dec 31, 2022 270,000.00
Sep 30, 2022 270,000.00
Jun 30, 2022 270,000.00
Mar 31, 2022 270,000.00
Dec 31, 2021 270,000.00
API Access

Mustang Bio Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MBIO&period=max&api_key=YOUR_API_KEY